Cargando…
Efficacy of Tegoprazan in Patients with Laryngopharyngeal Reflux Disease: A Preliminary Feasibility Study
Tegoprazan is a novel, potent, and highly selective potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset of action and prolonged control of gastric acidity. We performed a preliminary feasibility study to evaluate whether tegoprazan could control symptoms more eff...
Autores principales: | Jeon, Hye Kyung, Kim, Gwang Ha, Cheon, Yong-Il, Shin, Sung-Chan, Lee, Byung Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573336/ https://www.ncbi.nlm.nih.gov/pubmed/37834761 http://dx.doi.org/10.3390/jcm12196116 |
Ejemplares similares
-
Clinical Manifestations of Laryngopharyngeal Reflux
por: Han, Sung Yong, et al.
Publicado: (2016) -
Laryngopharyngeal Reflux
por: Karkos, Petros D., et al.
Publicado: (2012) -
Management of Laryngopharyngeal Reflux in Asia
por: Kim, Su Il, et al.
Publicado: (2020) -
Goiter and Laryngopharyngeal Reflux
por: Hamdan, Abdul-Latif, et al.
Publicado: (2012) -
Relationship between Depression and Laryngopharyngeal Reflux
por: Joo, Young-Hoon, et al.
Publicado: (2017)